ArticleBiotechnology and applied biochemistry2026

An In Silico Study of Resveratrol Derivatives as Dual Inhibitors of Cyclooxygenase-2 (COX-2) and 5-Lipoxygenase (5-LOX) in Cancer Therapy.

Sayali Doiphode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.